A novel phenoxy-bridged trinuclear nickel(ii) complex [Ni3(μ-L)2(bipy)3](1) (where H3L= (E)-2-hydroxy-N-(2-hydroxy-3,5-diiodophenyl)-3,5-diiodobenzohydrazonic acid, bipy = 2,2′-bipyridyl) has been designed and synthesized as a potential antivirus drug candidate.